BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12642745)

  • 1. Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study.
    Sørensen HT; Mellemkjaer L; Jepsen P; Thulstrup AM; Baron J; Olsen JH; Vilstrup H
    J Clin Gastroenterol; 2003 Apr; 36(4):356-9. PubMed ID: 12642745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.
    Mills SJ; Harrison SA
    Curr Gastroenterol Rep; 2005 Feb; 7(1):32-6. PubMed ID: 15701296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.
    Sorensen HT; Friis S; Olsen JH; Thulstrup AM; Mellemkjaer L; Linet M; Trichopoulos D; Vilstrup H; Olsen J
    Hepatology; 1998 Oct; 28(4):921-5. PubMed ID: 9755226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study.
    Askgaard G; Leon DA; Kjaer MS; Deleuran T; Gerds TA; Tolstrup JS
    Hepatology; 2017 Mar; 65(3):929-937. PubMed ID: 27862159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
    Jepsen P; Vilstrup H; Mellemkjaer L; Thulstrup AM; Olsen JH; Baron JA; Sørensen HT
    Hepatogastroenterology; 2003; 50(54):2101-4. PubMed ID: 14696473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of alcoholic liver disease in Denmark 2006-2011: a population-based study.
    Deleuran T; Vilstrup H; Becker U; Jepsen P
    Alcohol Alcohol; 2015 May; 50(3):352-7. PubMed ID: 25681463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013.
    Sahlman P; Nissinen M; Pukkala E; Färkkilä M
    Int J Cancer; 2016 Jun; 138(11):2616-21. PubMed ID: 26756434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.
    Wideroff L; Gridley G; Mellemkjaer L; Chow WH; Linet M; Keehn S; Borch-Johnsen K; Olsen JH
    J Natl Cancer Inst; 1997 Sep; 89(18):1360-5. PubMed ID: 9308706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.
    Chow WH; Johansen C; Gridley G; Mellemkjaer L; Olsen JH; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):640-4. PubMed ID: 10027343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study.
    Kornum JB; Sværke C; Thomsen RW; Lange P; Sørensen HT
    Respir Med; 2012 Jun; 106(6):845-52. PubMed ID: 22214771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease.
    Friis-Liby I; Aldenborg F; Jerlstad P; Rundström K; Björnsson E
    Scand J Gastroenterol; 2004 Sep; 39(9):864-9. PubMed ID: 15513385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of cancer among a cohort of 23,935 men and women with osteoporosis.
    McGlynn KA; Gridley G; Mellemkjaer L; Brinton LA; Anderson KC; Caporaso NE; Landgren O; Olsen JH
    Int J Cancer; 2008 Apr; 122(8):1879-84. PubMed ID: 18074348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, fatty liver and liver cancer.
    Qian Y; Fan JG
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):173-7. PubMed ID: 15908310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical course of alcoholic cirrhosis: development of comorbid diseases. A Danish nationwide cohort study.
    Jepsen P; Lash TL; Vilstrup H
    Liver Int; 2016 Nov; 36(11):1696-1703. PubMed ID: 27124269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study.
    Holland-Bill L; Christiansen CF; Farkas DK; Donskov F; Jørgensen JOL; Sørensen HT
    Acta Oncol; 2018 Apr; 57(4):522-527. PubMed ID: 28920509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.
    Deleuran T; Grønbaek H; Vilstrup H; Jepsen P
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1336-42. PubMed ID: 22490057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death.
    Semb S; Neermark S; Dam-Larsen S; Franzmann MB; Albrectsen J; Kallemose T; Becker U; Bendtsen F
    Scand J Gastroenterol; 2016 Nov; 51(11):1367-74. PubMed ID: 27381376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final results of a long-term, clinical follow-up in fatty liver patients.
    Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
    Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.